Production (Stage)
Bio-Techne Corporation
TECH
$46.78
-$0.54-1.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.14% | -29.45% | -38.91% | -41.07% | -25.18% |
| Total Depreciation and Amortization | -3.06% | -2.95% | -0.20% | 3.45% | 1.06% |
| Total Amortization of Deferred Charges | 5.19% | 5.19% | 5.19% | 5.19% | 9.11% |
| Total Other Non-Cash Items | 954.27% | 752.21% | 492.86% | 161.58% | 113.03% |
| Change in Net Operating Assets | -88.69% | 87.47% | 100.15% | 88.84% | 85.24% |
| Cash from Operations | -13.70% | 10.23% | 17.77% | 17.53% | 12.12% |
| Capital Expenditure | 20.87% | 1.22% | -38.26% | -64.41% | -35.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 100.00% | 98.03% | -67.72% | -67.72% |
| Divestitures | -- | -- | -- | -- | -100.00% |
| Other Investing Activities | -107.90% | 98.35% | 95.37% | 120.52% | 117.06% |
| Cash from Investing | 77.69% | 87.73% | 82.35% | 23.57% | 28.80% |
| Total Debt Issued | -83.11% | -100.00% | -80.30% | -63.69% | -63.69% |
| Total Debt Repaid | 52.91% | 0.68% | -32.55% | 51.30% | 59.51% |
| Issuance of Common Stock | 47.47% | 121.21% | 122.10% | 104.39% | 53.65% |
| Repurchase of Common Stock | -79.58% | 26.86% | -177.18% | -110.33% | 5.35% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.48% | -0.47% | -0.12% | -0.27% | -0.32% |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -158.36% | -278.12% | -263.17% | -641.20% | -358.05% |
| Foreign Exchange rate Adjustments | 144.03% | 163.43% | 7,649.34% | 30.48% | 1.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -94.02% | 237.24% | 334.28% | -459.57% | 137.67% |